{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Prostate+Fossa+Radiotherapy&page=2", "query": { "intervention": "Prostate Fossa Radiotherapy", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Prostate+Fossa+Radiotherapy&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T12:05:48.408Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06369610", "title": "Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Oligometastatic Prostate Carcinoma", "Prostate Adenocarcinoma" ], "interventions": [ { "name": "Abiraterone Acetate", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Gonadotropin-releasing Hormone Analog", "type": "BIOLOGICAL" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Radiation Therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "PROCEDURE", "BIOLOGICAL", "OTHER", "RADIATION" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2024-04-22", "completion_date": "2028-07-29", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-09-28T12:05:48.408Z", "location_count": 1, "location_summary": "Scottsdale, Arizona", "locations": [ { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06369610" }, { "nct_id": "NCT06496256", "title": "Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Barrigel", "type": "DEVICE" }, { "name": "Transrectal Ultrasound", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Palette Life Sciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 84, "start_date": "2024-10-31", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2025-05-29", "last_synced_at": "2026-09-28T12:05:48.408Z", "location_count": 4, "location_summary": "Boston, Massachusetts • Clifton, New Jersey • Austin, Texas + 1 more", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Clifton", "state": "New Jersey" }, { "city": "Austin", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06496256" }, { "nct_id": "NCT00551525", "title": "Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Radiotherapy", "type": "RADIATION" }, { "name": "Samarium 153", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "Radiation Therapy Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "MALE", "summary": "18 Years to 120 Years · Male only" }, "enrollment_count": 67, "start_date": "2008-04", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2017-07-25", "last_synced_at": "2026-09-28T12:05:48.408Z", "location_count": 29, "location_summary": "Phoenix, Arizona • Auburn, California • Cameron Park, California + 22 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Auburn", "state": "California" }, { "city": "Cameron Park", "state": "California" }, { "city": "Carmichael", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00551525" }, { "nct_id": "NCT04787744", "title": "Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Prostate Cancer", "Oligometastasis", "Oligorecurrence", "Recurrent Prostate Cancer", "Metastatic Prostate Cancer", "De Novo Prostate Cancer" ], "interventions": [ { "name": "PET-directed Local Therapy using Surgery", "type": "PROCEDURE" }, { "name": "PET-directed Local Therapy using Radiation", "type": "RADIATION" }, { "name": "Salvage Local Therapy for locally recurrent disease", "type": "OTHER" }, { "name": "Goserelin, Histrelin, Leuprolide & Triptorelin", "type": "DRUG" }, { "name": "ADT + Nilutamide, Flutamide, & Bicalutamide", "type": "DRUG" }, { "name": "Degarelix & Relugolix", "type": "DRUG" }, { "name": "ADT + Docetaxel +/- prednisone", "type": "DRUG" }, { "name": "ADT + Abiraterone + Prednisone", "type": "DRUG" }, { "name": "ADT + Abiraterone + Methylprednisolone", "type": "DRUG" }, { "name": "ADT + Apalutamide", "type": "DRUG" }, { "name": "ADT + Enzalutamide", "type": "DRUG" }, { "name": "Prostate-directed Radiation for De novo oligometastatic prostate cancer", "type": "RADIATION" } ], "intervention_types": [ "PROCEDURE", "RADIATION", "OTHER", "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 464, "start_date": "2021-07-01", "completion_date": "2029-03-30", "has_results": false, "last_update_posted_date": "2026-04-08", "last_synced_at": "2026-09-28T12:05:48.408Z", "location_count": 20, "location_summary": "Long Beach, California • West Los Angeles, California • Washington D.C., District of Columbia + 17 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "West Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Bay Pines", "state": "Florida" }, { "city": "Hines", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04787744" }, { "nct_id": "NCT04557059", "title": "A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostatic Neoplasms" ], "interventions": [ { "name": "Radiotherapy", "type": "RADIATION" }, { "name": "LHRHa", "type": "DRUG" }, { "name": "Apalutamide", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "Janssen Pharmaceutica N.V., Belgium", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 691, "start_date": "2020-11-12", "completion_date": "2031-09-15", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-09-28T12:05:48.408Z", "location_count": 13, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Lakewood, Colorado + 10 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Jeffersonville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04557059" }, { "nct_id": "NCT00969111", "title": "Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE", "type": "RADIATION" }, { "name": "Proton (prostate bed) to 70.2 CGE", "type": "RADIATION" }, { "name": "IMRT to 45 Gy; proton boost to prostate bed to 25.2 CGE", "type": "RADIATION" }, { "name": "Proton to 66.6 CGE", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Proton Collaborative Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 70, "start_date": "2009-08", "completion_date": "2050-08", "has_results": false, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-09-28T12:05:48.408Z", "location_count": 6, "location_summary": "Little Rock, Arkansas • Jacksonville, Florida • Warrenville, Illinois + 3 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Warrenville", "state": "Illinois" }, { "city": "Flint", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00969111" }, { "nct_id": "NCT02678520", "title": "Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "3-D Conformal Radiation Therapy", "type": "RADIATION" }, { "name": "Intensity Modulated Radiation Therapy", "type": "RADIATION" }, { "name": "Casodex, Zoladex , Lupron", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 0, "start_date": "2015-12", "completion_date": "2016-02", "has_results": false, "last_update_posted_date": "2016-07-22", "last_synced_at": "2026-09-28T12:05:48.408Z", "location_count": 1, "location_summary": "Fairway, Kansas", "locations": [ { "city": "Fairway", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02678520" }, { "nct_id": "NCT00734851", "title": "Multimodality Phase II Study in Prostate Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Docetaxel", "type": "DRUG" }, { "name": "Sunitinib", "type": "DRUG" }, { "name": "EBXRT", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 36, "start_date": "2008-12", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2015-12-23", "last_synced_at": "2026-09-28T12:05:48.408Z", "location_count": 3, "location_summary": "Baltimore, Maryland • New Brunswick, New Jersey • Durham, North Carolina", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "New Brunswick", "state": "New Jersey" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00734851" }, { "nct_id": "NCT07234981", "title": "PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "PSMA-guided Salvage Radiation", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "University of Nebraska", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "MALE", "summary": "30 Years and older · Male only" }, "enrollment_count": 54, "start_date": "2026-03-31", "completion_date": "2029-10-05", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-09-28T12:05:48.408Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT07234981" }, { "nct_id": "NCT00589472", "title": "Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Adenocarcinoma", "Stage I Prostate Cancer", "Stage IIA Prostate Cancer", "Stage IIB Prostate Cancer", "Stage III Prostate Cancer" ], "interventions": [ { "name": "Bicalutamide", "type": "DRUG" }, { "name": "Goserelin Acetate", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Leuprolide Acetate", "type": "DRUG" }, { "name": "Therapeutic Conventional Surgery", "type": "PROCEDURE" }, { "name": "Vorinostat", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "MALE", "summary": "19 Years and older · Male only" }, "enrollment_count": 19, "start_date": "2007-11", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2017-10-06", "last_synced_at": "2026-09-28T12:05:48.408Z", "location_count": 15, "location_summary": "Los Angeles, California • San Francisco, California • Chicago, Illinois + 12 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00589472" } ] }